Chen S, Yang Y, Wang R, Fang J, et al. Neoadjuvant PD-1/PD-L1 inhibitors combined with chemotherapy had a higher ORR than mono-immunotherapy in untreated HNSCC: Meta-analysis. Oral Oncol 2023;145:106479.
PMID: 37478574